Bristol Tequin Oral Suspension For Recurrent Otitis Media To Get Cmte. Review
This article was originally published in The Pink Sheet Daily
Gatifloxacin review will take place on May 10. FDA’s Anti-Infective Drugs Advisory Committee will discuss surrogate markers of efficacy for health care antiseptic drug products on May 11.
You may also be interested in...
FDA’s proposal for relabeling of antihypertensive agents is based on prior recommendations by the committee that information on cardiovascular outcomes related to blood pressure lowering be included as class labeling.
FDA’s Oncologic Drugs Advisory Committee will meet in Atlanta to review Bristol’s multi-targeted kinase inhibitor dasatinib for two leukemia indications.
FDA’s Psychopharmacologic Drugs Advisory Committee rules safety for modafinil product in children with attention deficit/hyperactivity disorder has not been adequately demonstrated.